NTM Patient Preferences Survey

On April 8th, 2019 the U.S. Food & Drug Administration will host a public workshop on the development of antibacterial drugs for the treatment of nontuberculous mycobacterial (NTM) infection.

At this workshop, we will convey patient experiences and preferences. Ahead of the workshop, we have published a survey to gather more information about patient preferences. We want to convey to drug developers and the FDA what you find helpful in a therapy. We would like to know more about your experience with NTM lung disease.

Please help us do this by taking the time now to complete this survey no later than March 25th, 2019. This survey should take 20-30 minutes to complete, but the time you spend on it now will lead to valuable steps forward in the development of new therapies for NTM lung disease.

Thank you.